Mouri Akihiro, Hoshino Yuta, Narusawa Shiho, Ikegami Keisuke, Mizoguchi Hiroyuki, Murata Yoshiharu, Yoshimura Takashi, Nabeshima Toshitaka
Department of Chemical Pharmacology, Meijo University Graduate School of Pharmaceutical Sciences, Nagoya 468-8503, Japan; Japanese Drug Organization of Appropriate Use and Research, Nagoya 468-0069, Japan.
Laboratory of Animal Physiology, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, Japan.
Psychoneuroendocrinology. 2014 Oct;48:147-61. doi: 10.1016/j.psyneuen.2014.05.021. Epub 2014 Jun 24.
Attention deficit/hyperactivity disorder (ADHD) has been reported in association with resistance to thyroid hormone, a disease caused by a mutation in the thyroid hormone receptor β (TRβ) gene. TRβ is a key protein mediating down-regulation of thyrotropin (TSH) expression by 3,3',5-tri-iodothyronine (T3), an active form of thyroid hormone. Dysregulation of TSH and its receptor (TSHR) is implicated in the pathophysiology of ADHD but the role of TSHR remains elusive. Here, we clarified a novel role for TSHR in emotional and cognitive functions related to monoaminergic nervous systems. TSHR knockout mice showed phenotypes of ADHD such as hyperactivity, impulsiveness, a decrease in sociality and increase in aggression, and an impairment of short-term memory and object recognition memory. Administration of methylphenidate (1, 5 and 10mg/kg) reversed impulsiveness, aggression and object recognition memory impairment. In the knockout mice, monoaminergic changes including decrease in the ratio of 3-methoxy-4-hydroxyphenylglycol/noradrenaline and increase in the ratio of homovanillic acid/dopamine were observed in some brain regions, accompanied by increase in the expression of noradrenaline transporter in the frontal cortex. When TSH was completely suppressed by the supraphysiological administration of T3 to the adult mice, some behavioral and neurological changes in TSHR KO mice were also observed, suggesting that these changes were not due to developmental hypothyroidism induced by the inactivation of TSHR but to the loss of the TSH-TSHR pathway itself. Taken together, the present findings suggest a novel role for TSHR in behavioral and neurological phenotypes of ADHD.
注意力缺陷多动障碍(ADHD)已被报道与甲状腺激素抵抗有关,甲状腺激素抵抗是一种由甲状腺激素受体β(TRβ)基因突变引起的疾病。TRβ是一种关键蛋白,可介导甲状腺激素的活性形式3,3',5-三碘甲状腺原氨酸(T3)对促甲状腺激素(TSH)表达的下调作用。TSH及其受体(TSHR)的失调与ADHD的病理生理学有关,但TSHR的作用仍不明确。在此,我们阐明了TSHR在与单胺能神经系统相关的情绪和认知功能中的新作用。TSHR基因敲除小鼠表现出ADHD的表型,如多动、冲动、社交性降低、攻击性增加以及短期记忆和物体识别记忆受损。给予哌甲酯(1、5和10mg/kg)可逆转冲动、攻击性和物体识别记忆受损。在基因敲除小鼠中,在一些脑区观察到单胺能变化,包括3-甲氧基-4-羟基苯乙二醇/去甲肾上腺素比值降低和高香草酸/多巴胺比值增加,同时额叶皮质中去甲肾上腺素转运体的表达增加。当通过对成年小鼠超生理剂量给予T3完全抑制TSH时,也观察到TSHR基因敲除小鼠的一些行为和神经学变化,这表明这些变化不是由于TSHR失活诱导的发育性甲状腺功能减退,而是由于TSH-TSHR通路本身的缺失。综上所述,目前的研究结果表明TSHR在ADHD的行为和神经学表型中具有新作用。